Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern

The high mutation rate of SARS-CoV-2 leads to emergence of several variants, some of which are resistant to vaccines and drugs targeting viral elements. Targeting host dependency factors, cell proteins required for viral replication, would help avoid resistance. However, whether different SARS-CoV-2...

Full description

Saved in:
Bibliographic Details
Published in:bioRxiv 2023-01
Main Authors: Frasson, Ilaria, Diamante, Linda, Zangrossi, Manuela, Carbognin, Elena, Anna Dalla Pieta, Penna, Alessandro, Rosato, Antonio, Verin, Ranieri, Torrigiani, Filippo, Salata, Cristiano, Vaccaro, Lorenzo, Cacchiarelli, Davide, Richter, Sara N, Montagner, Marco, Martello, Graziano
Format: Article
Language:English
Subjects:
Acetylcysteine
Antioxidants
COVID-19
CRISPR
Drug delivery
Drugs
Mutation rates
Severe acute respiratory syndrome coronavirus 2
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The high mutation rate of SARS-CoV-2 leads to emergence of several variants, some of which are resistant to vaccines and drugs targeting viral elements. Targeting host dependency factors, cell proteins required for viral replication, would help avoid resistance. However, whether different SARS-CoV-2 variants induce conserved cell responses and exploit the same core host factors is still unclear. We compared three variants of concern and observed that the host transcriptional response was conserved, differing only in kinetics and magnitude. By CRISPR screening we identified the host genes required for infection by each variant: most of the identified genes were shared by multiple variants, both in lung and colon cells. We validated our hits with small molecules and repurposed FDA-approved drugs. All drugs were highly effective against all tested variants, including delta and omicron, new variants that emerged during the study. Mechanistically, we identified ROS production as a pivotal step in early virus propagation. Antioxidant drugs, such as N-acetyl cysteine (NAC), were effective against all variants both in human lung cells, and in a humanised mouse model. Our study strongly supports the immediate use of available antioxidant drugs, such as NAC, as a general and effective anti-COVID-19 approach.Competing Interest StatementThe authors have declared no competing interest.Footnotes* We added experimental details about the use of NAC in figure 5.
DOI:10.1101/2023.01.09.523209